Interview with TeliaSonera's new CEO Johan Dennelind at TeliaSonera Group Head Offices, June 16 2013.
Nicox SA engages in the research, development and future commercialization of drug candidates. The company is applying its proprietary nitric...
Tekla Healthcare Investors ("HQH") is a diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker...
Stockholm 106 63
SIC Code: 4899